tiprankstipranks
Advertisement
Advertisement
Autolus Therapeutics price target raised to $10 from $9 at H.C. Wainwright
PremiumThe FlyAutolus Therapeutics price target raised to $10 from $9 at H.C. Wainwright
2M ago
Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)
Premium
The Fly
Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)
2M ago
Autolus Therapeutics backs FY26 revenue view $120M-$135M, consensus $129.39M
Premium
The Fly
Autolus Therapeutics backs FY26 revenue view $120M-$135M, consensus $129.39M
2M ago
Autolus Therapeutics to reduce workforce by approximately 13%
PremiumThe FlyAutolus Therapeutics to reduce workforce by approximately 13%
3M ago
Autolus Therapeutics: Strategic Positioning and Leadership Drive Confident Buy Rating
Premium
Ratings
Autolus Therapeutics: Strategic Positioning and Leadership Drive Confident Buy Rating
3M ago
Autolus Therapeutics files to sell 54.58M American Depositary Shares for holders
Premium
The Fly
Autolus Therapeutics files to sell 54.58M American Depositary Shares for holders
3M ago
Autolus: Transition-Year Execution and Aucatzyl Expansion Underscore Buy-Rated Long-Term Upside
PremiumRatingsAutolus: Transition-Year Execution and Aucatzyl Expansion Underscore Buy-Rated Long-Term Upside
4M ago
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
Premium
The Fly
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
4M ago
Autolus Highlights AUCATZYL Launch and Pipeline Advancements
Premium
Company Announcements
Autolus Highlights AUCATZYL Launch and Pipeline Advancements
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100